| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 731,186,042.28 | 2,874,808,410.25 | 2,168,919,321.05 | 1,414,575,682.63 |
| 收到的税费返还 | 6,655,886.86 | 138,831,891.05 | 124,207,846.94 | 107,218,814.41 |
| 收到其他与经营活动有关的现金 | 73,779,020.12 | 112,989,676.05 | 99,858,693.31 | 78,737,613.42 |
| 经营活动现金流入小计 | 811,620,949.26 | 3,126,629,977.35 | 2,392,985,861.3 | 1,600,532,110.46 |
| 购买商品、接受劳务支付的现金 | 513,175,480.08 | 2,094,316,827.6 | 1,477,274,226.75 | 933,116,743.29 |
| 支付给职工以及为职工支付的现金 | 119,919,164.35 | 456,690,509.15 | 349,912,705.32 | 246,824,805.43 |
| 支付的各项税费 | 15,772,596.12 | 95,675,357.46 | 56,629,703.91 | 10,044,011.7 |
| 支付其他与经营活动有关的现金 | 8,504,816.25 | 75,251,552.86 | 59,074,887.82 | 34,988,744.42 |
| 经营活动现金流出小计 | 657,372,056.8 | 2,721,934,247.07 | 1,942,891,523.8 | 1,224,974,304.84 |
| 经营活动产生的现金流量净额 | 154,248,892.46 | 404,695,730.28 | 450,094,337.5 | 375,557,805.62 |
| 二、投资活动产生的现金流量: | | | | |
| 收回投资收到的现金 | 7,415,990,000 | 7,265,000,000 | 2,400,000,000 | - |
| 取得投资收益收到的现金 | 12,356,650.81 | 8,554,837.2 | 2,951,394.06 | - |
| 收到的其他与投资活动有关的现金 | - | 24,195,666 | 24,195,666 | 24,195,666 |
| 投资活动现金流入小计 | 7,428,346,650.81 | 7,297,750,503.2 | 2,427,147,060.06 | 24,195,666 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 439,544,262.28 | 2,247,394,247.81 | 1,677,912,372.22 | 1,019,178,898.08 |
| 投资支付的现金 | 6,885,020,000 | 9,015,058,236.1 | 2,700,000,000 | - |
| 投资活动现金流出小计 | 7,324,564,262.28 | 11,262,452,483.91 | 4,377,912,372.22 | 1,019,178,898.08 |
| 投资活动产生的现金流量净额 | 103,782,388.53 | -3,964,701,980.71 | -1,950,765,312.16 | -994,983,232.08 |
| 三、筹资活动产生的现金流量: | | | | |
| 吸收投资收到的现金 | - | 4,543,119,280 | - | - |
| 取得借款收到的现金 | 25,256,364.85 | 2,541,938,949.45 | 1,867,195,314.3 | 533,975,314.3 |
| 筹资活动现金流入小计 | 25,256,364.85 | 7,085,058,229.45 | 1,867,195,314.3 | 533,975,314.3 |
| 偿还债务支付的现金 | 1,431,107,668.35 | 3,087,023,474.67 | 1,356,093,436.96 | 243,535,427.41 |
| 分配股利、利润或偿付利息支付的现金 | 31,606,355.13 | 188,436,715.4 | 141,893,367.03 | 94,936,620.82 |
| 支付其他与筹资活动有关的现金 | 6,738,441.33 | 49,528,311.62 | 20,117,783.64 | 11,290,043.61 |
| 筹资活动现金流出小计 | 1,469,452,464.81 | 3,324,988,501.69 | 1,518,104,587.63 | 349,762,091.84 |
| 筹资活动产生的现金流量净额 | -1,444,196,099.96 | 3,760,069,727.76 | 349,090,726.67 | 184,213,222.46 |
| 四、汇率变动对现金及现金等价物的影响 | -3,439,286.59 | -9,499,356.37 | -471,847.36 | -1,247,334.21 |
| 五、现金及现金等价物净增加额 | -1,189,604,105.56 | 190,564,120.96 | -1,152,052,095.35 | -436,459,538.21 |
| 加:期初现金及现金等价物余额 | 3,452,286,993.67 | 3,261,722,872.71 | 3,261,722,872.71 | 3,261,722,872.71 |
| 期末现金及现金等价物余额 | 2,262,682,888.11 | 3,452,286,993.67 | 2,109,670,777.36 | 2,825,263,334.5 |
| 补充资料: | | | | |
| 净利润 | - | -738,170,786.01 | - | -340,254,488.66 |
| 资产减值准备 | - | 200,208,445.37 | - | 89,163,829.07 |
| 固定资产和投资性房地产折旧 | - | 1,135,143,338.54 | - | 558,336,241.72 |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 1,135,143,338.54 | - | 558,336,241.72 |
| 无形资产摊销 | - | 14,561,129.74 | - | 7,029,994.09 |
| 长期待摊费用摊销 | - | 3,875,404.07 | - | 1,915,487.86 |
| 递延收益摊销 | - | -15,378,935.25 | - | -7,686,058.53 |
| 处置固定资产、无形资产和其他长期资产的损失 | - | -264,330.9 | - | - |
| 财务费用 | - | 204,347,043.9 | - | 105,886,306.39 |
| 投资损失 | - | -10,785,420.54 | - | - |
| 存货的减少 | - | -499,874,411.47 | - | -205,773,586.66 |
| 经营性应收项目的减少 | - | 25,480,536.04 | - | -27,486,979.89 |
| 经营性应付项目的增加 | - | -198,663,579.11 | - | 82,897,725.29 |
| 其他 | - | 820,574.86 | - | - |
| 现金的期末余额 | - | 3,452,286,993.67 | - | 2,825,263,334.5 |
| 减:现金的期初余额 | - | 3,261,722,872.71 | - | 3,261,722,872.71 |
| 现金及现金等价物的净增加额 | - | 190,564,120.96 | - | -436,459,538.21 |
| 公告日期 | 2026-04-21 | 2026-04-21 | 2025-10-24 | 2025-08-07 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |